Physician profile
Phoebe D Lu
NPI 1841495546
$922.69
in general payments reported to CMS, 2019-2025
22 companies · $86.31 in 2025
The $86.31 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $72.01 · 2022: $206 · 2023: $108 · 2024: $48.81 · 2025: $86.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $162.01 | 2019-2023 | Dupixent |
| Pfizer INC. | $79.76 | 2019-2023 | |
| Leo Pharma INC. | $67.26 | 2022-2025 | Anzupgo |
| Galderma Laboratories, L.P. | $66.47 | 2019-2022 | |
| Celgene Corporation | $60.75 | 2019 | |
| Amgen INC. | $56.10 | 2019-2025 | Otezla, Otezla |
| Genzyme Corporation | $50.93 | 2019-2022 | |
| Janssen Biotech, INC. | $42.93 | 2019-2023 | Simponi Aria, Simponi, Stelara |
| Incyte Corporation | $35.08 | 2022 | |
| Dermavant Sciences, INC. | $34.28 | 2023 | Vtama |
| Lilly USA, LLC | $34.21 | 2022-2024 | Taltz |
| Biofrontera INC. | $30.00 | 2019 | |
| Abbvie INC. | $29.87 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.31 | 2020-2024 | Cabtreo |
| Aclaris Therapeutics, INC. | $29.13 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $27.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.36 | 2024 | Sotyktu |
| Sandoz INC. | $15.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.00 | 2019 | |
| Vyne Pharmaceuticals INC. | $14.09 | 2020 | |
| Almirall LLC | $13.03 | 2019 | |
| Merck Sharp & Dohme LLC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phoebe Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.